Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Cervical Cancer

  Free Subscription


16.03.2026

1 Abdom Radiol (NY)
1 Acad Radiol
1 Acta Cytol
1 Afr J Reprod Health
1 Altern Ther Health Med
1 Anal Chem
2 Anticancer Res
1 Appl Microbiol Biotechnol
4 Asian Pac J Cancer Prev
1 Biochem Biophys Res Commun
1 Biomed Environ Sci
1 Biomol Biomed
5 BMC Cancer
1 BMC Infect Dis
1 BMC Public Health
2 BMC Womens Health
1 Br J Hosp Med (Lond)
1 Bull Cancer
1 Cancer
1 Cancer Biother Radiopharm
3 Cancer Control
2 Cancer Epidemiol
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Immunol Immunother
4 Cancer Med
2 Cancer Nurs
1 Cancer Sci
1 Cell Mol Life Sci
1 Cell Rep
1 Chin Clin Oncol
1 Clin Radiol
1 Commun Med (Lond)
1 Comput Biol Chem
2 Cureus
3 Ecancermedicalscience
1 Endocr Relat Cancer
1 ESMO Open
1 Eur J Surg Oncol
2 Eur Rev Med Pharmacol Sci
1 Exp Oncol
3 Front Immunol
1 Front Public Health
1 Glob Health Action
2 Gynecol Oncol
2 Health Sci Rep
1 Helminthologia
1 Histol Histopathol
2 Histopathology
1 Hum Pathol
1 Insights Imaging
1 Int Immunopharmacol
4 Int J Cancer
1 Int J Clin Oncol
1 Int J Gynaecol Obstet
5 Int J Gynecol Cancer
1 Int J Med Sci
1 Int J Oncol
1 Int J Surg Pathol
1 Int J Womens Health
1 Iran J Immunol
1 iScience
1 J Biochem Mol Toxicol
1 J Cachexia Sarcopenia Muscle
4 J Cancer Policy
2 J Cancer Res Clin Oncol
1 J Clin Microbiol
1 J Clin Oncol
1 J Community Health
2 J Gynecol Oncol
1 J Immunother
1 J Infect
1 J Infect Chemother
1 J Med Biochem
2 J Obstet Gynaecol Res
1 J Prev (2022)
2 J Public Health (Oxf)
1 J Theor Biol
1 J Transl Med
2 JAMA Netw Open
1 JNMA J Nepal Med Assoc
1 Med Chem
2 Medicine (Baltimore)
1 Microbiol Resour Announc
1 Mil Med
1 Nanomedicine
1 Nanomedicine (Lond)
1 Nat Commun
1 Nature
1 Neuro Endocrinol Lett
1 NPJ Precis Oncol
1 Nucleic Acids Res
1 Nutr Rev
1 Obstet Gynecol Sci
1 Phys Med Biol
2 PLoS One
1 Radiat Oncol
1 Radiother Oncol
1 Reprod Toxicol
1 Res Sq
2 Rev Med Virol
1 RNA Biol
6 Sci Rep
1 Semin Oncol Nurs
1 Sensors (Basel)
4 Taiwan J Obstet Gynecol
1 Technol Cancer Res Treat
1 Ther Adv Med Oncol
1 Transl Cancer Res
1 Trials
1 Virol J
3 Virologie (Montrouge)
2 Viruses
2 Womens Health (Lond)
1 World J Surg Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Abdom Radiol (NY)

  1. PAIVA SANTOS J, Prata R, Serrado MA, Cunha TM, et al
    Evaluating lymph node metastases in cervical cancer: the added value of T2/DWI MRI fusion compared to standard MRI alone and 18 F-FDG PET/CT.
    Abdom Radiol (NY). 2026 Mar 9. doi: 10.1007/s00261-026-05415.
    PubMed         Abstract available


    Acad Radiol

  2. REN W, Cui Z, Wu S, Shen F, et al
    A Clinical-DKI Fusion Model for Objective Pretreatment Prediction of Parametrial Invasion in Cervical Cancer.
    Acad Radiol. 2026 Mar 2:S1076-6332(26)00108-X. doi: 10.1016/j.acra.2026.
    PubMed         Abstract available


    Acta Cytol

  3. MARTINS TR, Witkin SS, de Oliveira RL, Gadelha JGS, et al
    EVALUATION AND RECOMMENDATIONS TO MODERNIZE CERVICAL CANCER DETECTION AND PREVENTION PROGRAMS IN BRAZIL: CHALLENGES AND OPPORTUNITIES - A NARRATIVE REVIEW.
    Acta Cytol. 2026 Mar 9:1-20. doi: 10.1159/000550725.
    PubMed         Abstract available


    Afr J Reprod Health

  4. BOUBLENZA L, Nahet A, Masdoua N, Sadouki N, et al
    Prevalence of human papillomavirus infection among women at a gynaecological clinic in Tlemcen, Algeria.
    Afr J Reprod Health. 2023;27:56-63.
    PubMed         Abstract available


    Altern Ther Health Med

  5. ZHAO J, Liu X, Gao J, Xiao H, et al
    Factors Associated with Lesion Recurrence Following Cervical Conization.
    Altern Ther Health Med. 2023;29:50-55.
    PubMed         Abstract available


    Anal Chem

  6. TANG X, Peng X, Zhang W, Li Z, et al
    Ultrasensitive Electrochemiluminescence Nanoprobe for Early Screening and Early Diagnosis of Cervical Cancer.
    Anal Chem. 2026 Mar 11. doi: 10.1021/acs.analchem.5c08162.
    PubMed         Abstract available


    Anticancer Res

  7. MASUMOTO S, Tanaka M, Yamamoto K, Hori Y, et al
    HPV18-positive Small Cell Neuroendocrine Carcinoma of the Uterine Cervix Treated With Immunotherapy: A Case Report.
    Anticancer Res. 2026;46:1733-1739.
    PubMed         Abstract available

  8. SAILLANT A, Rasclard M, Gaume JB, Souchaud O, et al
    A Case of Anti-3-hydroxy-3-methylglutaryl-coenzyme A Reductase Myopathy Associated With Advanced Cervical Carcinoma.
    Anticancer Res. 2023;43:4723-4727.
    PubMed         Abstract available


    Appl Microbiol Biotechnol

  9. HUANG B, Lou Y, Zeng Z, Kan X, et al
    A Cas12a-based fluorescent microfluidic system for rapid on-site human papillomavirus diagnostics.
    Appl Microbiol Biotechnol. 2023;107:6287-6297.
    PubMed         Abstract available


    Asian Pac J Cancer Prev

  10. SUSHMA N, C R TP, Y S N, Kaginelli S, et al
    Analysis of In-Vivo Dose Measurement of Urethra Using Array MOSFET Detectors and TPS-Calculated Dose in High-Dose-Rate Interstitial Brachytherapy in Gynaecological Malignancies.
    Asian Pac J Cancer Prev. 2026;27:1091-1098.
    PubMed         Abstract available

  11. SRIVASTAVA H, Raghuvanshi S, Bhalla S, Raghuvanshi S, et al
    PIK3CA Polymorphisms in Cervical Cancer: Differential Impact of rs6443624 and rs141178472.
    Asian Pac J Cancer Prev. 2026;27:1061-1068.
    PubMed         Abstract available

  12. FATIHA RA, Ngabdi CK, Azizah JS, Putri BSN, et al
    Disruption of EMT Signaling and Migration by Moringa oleifera Leaf Powder-Silver Nanoparticles (MOLP-AgNPs) in HeLa Cervical Cancer Cells.
    Asian Pac J Cancer Prev. 2026;27:981-988.
    PubMed         Abstract available

  13. MOSAVI JARRAHI A, Rajaie S, Azari S, Karimi F, et al
    Standardizing Cost-Effectiveness Evidence for Cancer Prevention: A Case Study Analysis of HPV Vaccination.
    Asian Pac J Cancer Prev. 2026;27:789-792.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  14. AZIZAH JS, Ngabdi CK, Fatiha RA, To SW, et al
    Physicochemical characterization and anticancer potential of Ficus deltoidea-silver nanoparticles (FD-AgNPs) on HeLa cells: Evidence from apoptosis and proliferation assays.
    Biochem Biophys Res Commun. 2026;808:153407.
    PubMed         Abstract available


    Biomed Environ Sci

  15. JI LY, Wang X, Jiao RX, Yang J, et al
    Application of Cytokines in Cervical Secretion for High-grade Squamous Intraepithelial Lesion Caused by High-risk Human Papillomavirus Infection.
    Biomed Environ Sci. 2026;39:215-222.
    PubMed         Abstract available


    Biomol Biomed

  16. ZHANG X, Yin Y, Yang T, Cong Y, et al
    HALP outperforms systemic inflammatory biomarkers for prognosis in locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Biomol Biomed. 2026 Mar 10. doi: 10.17305/bb.2026.13993.
    PubMed         Abstract available


    BMC Cancer

  17. CUI YM, Shan YM, Xiao YY, Gao Y, et al
    Analysis of prognosis in early-stage cervical cancer patients post-conization treated with laparoscopic versus open radical hysterectomy.
    BMC Cancer. 2026 Mar 10. doi: 10.1186/s12885-026-15756.
    PubMed        

  18. OUMA GE, Asaso Omwodo K, Itsura P, Poli PA, et al
    Characterizing trimodal therapy outcomes by HIV status in early-stage cervical cancer: a retrospective cohort study from a Kenyan tertiary center.
    BMC Cancer. 2026 Mar 9. doi: 10.1186/s12885-026-15761.
    PubMed        

  19. WU M, Jiang Z, Xian X, Lu M, et al
    Transrectal ultrasound-guided optimization of needle insertion for interstitial brachytherapy in the treatment of vaginal stump recurrence of cervical cancer.
    BMC Cancer. 2026 Mar 7. doi: 10.1186/s12885-026-15819.
    PubMed        

  20. CHEN X, Li J, Sun Y, Ye Z, et al
    LncRNA EGFR-AS1 inhibits ferroptosis to reduce radiosensitivity of cervical cancer through the m6A/IGF2BP3/APAF1 axis.
    BMC Cancer. 2026 Mar 5. doi: 10.1186/s12885-026-15596.
    PubMed        

  21. ABERA GB, Alemayehu M, Sori DA, Ali R, et al
    Time to death and its determinants among cervical cancer patients in Tigray, Ethiopia: a retrospective follow up study.
    BMC Cancer. 2026 Mar 2. doi: 10.1186/s12885-026-15712.
    PubMed         Abstract available


    BMC Infect Dis

  22. MENGISTIE MB, Ayalew WL, Mengistie SK, Gebeyehu AS, et al
    Prevalence of cervical cancer and its associated factors among women living with HIV attending public referral hospitals in Amhara Region, Ethiopia, 2025, a cross-sectional study.
    BMC Infect Dis. 2026 Feb 28. doi: 10.1186/s12879-026-12976.
    PubMed        


    BMC Public Health

  23. KIVUTI-BITOK LW, Mugo CW, Mituki D, Marete C, et al
    The effect of school-based educational session on knowledge, attitudes, and beliefs of cervical cancer among adolescents in mixed day high schools in Embu County: a quasi-experimental study.
    BMC Public Health. 2026 Mar 11. doi: 10.1186/s12889-026-26675.
    PubMed         Abstract available


    BMC Womens Health

  24. LEONARDSEN AL, Englund E, Trope A, Stensrud M, et al
    The effect of a cervical testing campaign on incarcerated females- a repeated cross-sectional study in Norwegian prisons.
    BMC Womens Health. 2026;26:141.
    PubMed         Abstract available

  25. LI P, Wang H
    The diagnostic value of colposcopy in postmenopausal women: a retrospective study.
    BMC Womens Health. 2026;26:140.
    PubMed         Abstract available


    Br J Hosp Med (Lond)

  26. WILLIAMS HR, Kelly D
    Prevention and Diagnosis of Cervical Cancers in the UK and Europe: What Have We Learned in the Last 10 Years and What Is Next?
    Br J Hosp Med (Lond). 2026;87:50727.
    PubMed         Abstract available


    Bull Cancer

  27. PAUTIER P, Genestie C, Gladieff L, Kurtz JE, et al
    [Not Available].
    Bull Cancer. 2023;110.
    PubMed         Abstract available


    Cancer

  28. HAN K
    Advancing molecular residual disease detection in cervical cancer through next-generation sequencing of circulating human papillomavirus DNA.
    Cancer. 2026;132:e70352.
    PubMed        


    Cancer Biother Radiopharm

  29. ZHANG L, Quan R, Huang H, Wu M, et al
    Boronophenylalanine-Mediated Boron Neutron Capture Therapy Confers Selective Killing of Cervical Cancer by Exploiting DNA Repair Deficiency.
    Cancer Biother Radiopharm. 2026 Mar 12:10849785261426657.
    PubMed         Abstract available


    Cancer Control


  30. Corrigendum to "Prevalence of Human Papillomavirus Subtypes and Related Cytology in Estonian Cervical Cancer Screening Population in 2021".
    Cancer Control. 2026;33:10732748261431083.
    PubMed        

  31. GAO H, Gao Q, Xue L, Lin H, et al
    Risk Stratification for Underlying Cervical Intraepithelial Neoplasia Grade (CIN)3+ in Reproductive-Age Women With Biopsy-Confirmed CIN2: Implications for Fertility-Preserving Management.
    Cancer Control. 2026;33:10732748261427836.
    PubMed         Abstract available

  32. SSETAALA A, Muwonge I, Namulwa D, Kyakuwa N, et al
    Cervical Cancer Screening in Uganda: Determinants of Past Screening and Post-Education Uptake; A Cross-Sectional Survey.
    Cancer Control. 2026;33:10732748261427062.
    PubMed         Abstract available


    Cancer Epidemiol

  33. XUE L, Hao S, Sun H, Du L, et al
    Spatial clustering of gynecological cancers in China: A countrywide migration-adjusted analysis at the district level.
    Cancer Epidemiol. 2026;101:103023.
    PubMed         Abstract available

  34. ZHANG C, Li X, Zhong L, Wang Y, et al
    Assessment of the relationships between invasive endocervical adenocarcinoma and human papillomavirus infection and distribution characteristics in China: According to the new WHO classification criteria in 2020.
    Cancer Epidemiol. 2023;86:102442.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  35. ISAACSON S, Spees LP, Hudgens MG, Pence BW, et al
    Racial differences in expected versus actual costs of cervical cancer screening among low-income, under-screened women in North Carolina.
    Cancer Epidemiol Biomarkers Prev. 2026 Mar 2. doi: 10.1158/1055-9965.EPI-25-0885
    PubMed         Abstract available


    Cancer Immunol Immunother

  36. KONG W, Liu P, Zhang J, Liu Q, et al
    Chemoradiotherapy facilitates siglec-10(+)/siglec-9(+) macrophage-mediated impairment of CD24(+)/MUC16(+) tumor cell elimination and enhances PD-L2 dependent immunosuppression in cervical cancer.
    Cancer Immunol Immunother. 2026;75:97.
    PubMed         Abstract available


    Cancer Med

  37. HUANG J, Li X, Zhuang Y, Zhang Z, et al
    Nomogram Prediction Model and Prognostic Comparison of Cervical Clear Cell Carcinoma and Cervical Endometrioid Adenocarcinoma: A SEER Database Study.
    Cancer Med. 2026;15:e71699.
    PubMed         Abstract available

  38. JIA M, Zeng S, Zou J, Chen H, et al
    Predicting Risk of Lymph Node Metastasis in Neuroendocrine Carcinoma of Cervix: A Validated Nomogram Incorporating Neuroendocrine Markers and Clinical Parameters.
    Cancer Med. 2026;15:e71686.
    PubMed         Abstract available

  39. ULMER KK, Sargent MD, Cina KR, Vinson AH, et al
    Native American Women's Willingness to Screen for Both Cervical and Colorectal Cancer at Home.
    Cancer Med. 2026;15:e71654.
    PubMed         Abstract available

  40. KOTIAN N, Reddy Y, Pai P, Sundara BK, et al
    A Critical Analysis of the Impact of Etoposide as a Topoisomerase II Inhibitor in Cervical Cancer Treatment: A Review.
    Cancer Med. 2026;15:e71482.
    PubMed         Abstract available


    Cancer Nurs

  41. CAKIR Z, Gok Ugur H
    The Effect of Motivational Interviewing Based on the COM-B Model on Women's Cervical Cancer Health Beliefs and Participation in Screening: A Single-Blind Randomized Controlled Trial.
    Cancer Nurs. 2026 Mar 10. doi: 10.1097/NCC.0000000000001553.
    PubMed         Abstract available

  42. BAHARVAND S, Asghari-Jafarabadi M, Nourizadeh R, Sattarzadeh Jahdi N, et al
    The Effect of Decision Aid on Satisfaction With Decision and Anxiety Among Women With Abnormal Cervical Screening Results.
    Cancer Nurs. 2023;46:E405-E411.
    PubMed         Abstract available


    Cancer Sci

  43. WANG Z, Zhuang L, Liu S, Cao C, et al
    Single-Cell and Multiomic Analysis Reveals Neutrophil Heterogeneity and Prognostic Value in Cervical Lesions.
    Cancer Sci. 2026;117:597-612.
    PubMed         Abstract available


    Cell Mol Life Sci

  44. ZHANG Y, Gao Y, Guan X, Wang E, et al
    LILRB4 shapes an immunosuppressive microenvironment to drive cervical cancer progression through tumor-infiltrating myeloid cell expansion and CD8(+) T-cell suppression.
    Cell Mol Life Sci. 2026;83:146.
    PubMed         Abstract available


    Cell Rep

  45. LI C, Zhao H, Wang J, Liu C, et al
    A tumor-resident bacterium promotes cervical cancer progression through lysoPC-mediated c-Jun/c-Fos activation.
    Cell Rep. 2026;45:117079.
    PubMed         Abstract available


    Chin Clin Oncol

  46. SANCHEZ DIAZ E, Levin G, Fernandes A, Fletcher A, et al
    Clinical evidence on a Coriolus versicolor-based vaginal gel for HPV-related cervical disease: a narrative review.
    Chin Clin Oncol. 2026;15:9.
    PubMed         Abstract available


    Clin Radiol

  47. YIN L, Zhang J, Pang Y, Mou Y, et al
    Predictive value of R2 * values derived from blood oxygen level-dependent magnetic resonance imaging for lymph node metastasis after neoadjuvant chemotherapy for cervical squamous cell carcinoma.
    Clin Radiol. 2026;94:107149.
    PubMed         Abstract available


    Commun Med (Lond)

  48. VAN KEER S, van den Helder R, Teblick L, De Smet A, et al
    Clinical performance of ASCL1/LHX8 DNA methylation on first-void urine to screen for cervical cancer.
    Commun Med (Lond). 2026 Mar 12. doi: 10.1038/s43856-026-01512.
    PubMed         Abstract available


    Comput Biol Chem

  49. RASHEED A, Shirazi SH, Khan P, Aseere AM, et al
    cervical nuclei segmentation through synergic conditional generative adversarial network in cervical smear images.
    Comput Biol Chem. 2026;122:108918.
    PubMed         Abstract available


    Cureus

  50. BODHARE T, Bele S, V S, Sheela Kumari K S, et al
    An Intervention Study Assessing the Effects of a Breast and Cervical Cancer Health Education Program on Knowledge, Attitudes, and Practices Among Adolescent Female Students in Madurai, South India.
    Cureus. 2026;18:e103131.
    PubMed         Abstract available

  51. ACHARYA GC, Das S, Jasuja A, Debata I, et al
    Perception, Practices, and Barriers to Cervical Cancer Screening Among Women in Rural and Urban Slums of Eastern India: A Community-Based Cross-Sectional Study.
    Cureus. 2026;18:e102449.
    PubMed         Abstract available


    Ecancermedicalscience

  52. EL-MOGASSABI A, Baiu HS, Hassan NO, Salem EM, et al
    Translation, adaptation and validation of the AWACAN tool for breast and cervical cancer awareness among Arabic-speaking women: a study from Libya.
    Ecancermedicalscience. 2025;19:2047.
    PubMed         Abstract available

  53. PUENTE-VALLEJO R, Garcia-Gutierrez A, Jara-Jimenez S, Mosquera-Ruiz MN, et al
    Impact of treatment delay on survival in women diagnosed with cervical cancer in Quito, Ecuador: a retrospective cohort study.
    Ecancermedicalscience. 2025;19:2039.
    PubMed         Abstract available

  54. DAS NEVES MAB, Galvao ND, de Lima FCDS, Oliveria JFP, et al
    Factors associated with advanced diagnosis of cervical cancer: a hospital-based retrospective study in a state of the Brazilian Legal Amazon.
    Ecancermedicalscience. 2025;19:2045.
    PubMed         Abstract available


    Endocr Relat Cancer

  55. VALENZA C, Spada F, Multinu F, Benini L, et al
    Multimodal treatment for resectable neuroendocrine carcinoma of the cervix.
    Endocr Relat Cancer. 2023;30:e230112.
    PubMed         Abstract available


    ESMO Open

  56. RYU SY, Nam BH, Kim MH, Jang WI, et al
    A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) study.
    ESMO Open. 2026;11:106102.
    PubMed         Abstract available


    Eur J Surg Oncol

  57. ZHANG G, Zhang X, Li H, Du X, et al
    Multi-omic and immune landscapes of HPV-negative versus HPV-positive cervical cancer reveal implications for immunotherapy.
    Eur J Surg Oncol. 2026;52:111425.
    PubMed         Abstract available


    Eur Rev Med Pharmacol Sci

  58. VILLANUEVA-AGUILAR ME, Rizo-de la Torre LC, Bencomo-Alvarez AE, Gallegos-Arreola MP, et al
    Sequence analysis of exons 30 and 31 of LAMA3 gene variants and its association with human papillomavirus infection predisposition: no evidence was found.
    Eur Rev Med Pharmacol Sci. 2023;27:6860-6866.
    PubMed         Abstract available

  59. ALHARBI SA, Alshammari FD, Humaida MI, Abdalhabib EK, et al
    The cytological pattern of cervical smears of a series of Saudi women in one gynecologic center.
    Eur Rev Med Pharmacol Sci. 2023;27:6785-6791.
    PubMed         Abstract available


    Exp Oncol

  60. SVINTSITSKY V, Yegorov M, Stakhovsky E, Vitruk Y, et al
    NON-STANDARD STRATEGIES IN THE TREATMENT OF ADVANCED CERVICAL CANCER: A CASE SERIES.
    Exp Oncol. 2026;47:467-477.
    PubMed         Abstract available


    Front Immunol

  61. ZHOU J, Ye W, Ranarisoa SN, Tian L, et al
    Comparison of drug regimens for recurrent or metastatic cervical cancer: a systematic review and network meta-analysis.
    Front Immunol. 2026;17:1775409.
    PubMed         Abstract available

  62. ZHOU G, Chen W, Dong X, Guo Q, et al
    Nocardia rubra cell wall skeleton-induced MARCO expression: implications for improved phagocytosis and cytokine secretion in tumor-associated macrophages.
    Front Immunol. 2026;17:1611476.
    PubMed         Abstract available

  63. ZELINI P, Zavaglio F, Dominioni M, Valsecchi M, et al
    Detection of human papillomavirus (HPV)-specific T cell response in women with low-grade cervical intraepithelial lesion and HPV vaccinated subjects.
    Front Immunol. 2026;16:1733404.
    PubMed         Abstract available


    Front Public Health

  64. LI G, Lu Z, Yin F, Lu H, et al
    High-risk HPV and bacterial STIs in a primary screening population in rural Hainan, China: prevalence, co-infection, and association with cervical abnormalities.
    Front Public Health. 2026;14:1773020.
    PubMed         Abstract available


    Glob Health Action

  65. BERHANU W, Yigremachew S, Hanson C, Avermark H, et al
    A missed opportunity: faith leaders and the HPV vaccination effort in Addis Ababa, Ethiopia.
    Glob Health Action. 2026;19:2635822.
    PubMed         Abstract available


    Gynecol Oncol

  66. MOREL D, Parvu V, Andrews J, Stephenson P, et al
    HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay.
    Gynecol Oncol. 2026;207:40-47.
    PubMed         Abstract available

  67. SAAB RH, Salvo G, Gonzales NR, Munsell MF, et al
    Social media use is associated with higher levels of anxiety and depression in patients with neuroendocrine carcinoma of the cervix: A NeCTuR study.
    Gynecol Oncol. 2023;177:95-102.
    PubMed         Abstract available


    Health Sci Rep

  68. TAWE L
    Mapping the HPV Detection Landscape in Botswana: A Narrative Review of Diagnostic Platforms and Their Impact on Cervical Cancer Control.
    Health Sci Rep. 2026;9:e72038.
    PubMed         Abstract available

  69. KYEI-ARTHUR F, Agyekum MW, Afrifa-Anane GF, Alhassan N, et al
    Cervical Cancer Screening Prevalence and Predictors Among Women Aged 25-49 Years in Ghana: A Cross-Sectional Study.
    Health Sci Rep. 2026;9:e71971.
    PubMed         Abstract available


    Helminthologia

  70. MATHOBELA MN, Chuang TW, Chen PC, Motsa MPS, et al
    Prevalence and factors associated with urinary schistosomiasis in women attending cervical cancer screening in Sithobela, Eswatini: A facility-based cross-sectional study.
    Helminthologia. 2025;62:296-303.
    PubMed         Abstract available


    Histol Histopathol

  71. ZHAO J, Wang L, Shao N, Qu Y, et al
    RRM2/GCH1 signaling decreased cisplatin sensitivity in cervical cancer by modulating the ferroptosis process.
    Histol Histopathol. 2026 Mar 6:25056. doi: 10.14670.
    PubMed         Abstract available


    Histopathology

  72. LEE YS, Yim K, Kim CJ, Kim JH, et al
    Tumour budding in pretreatment cervical biopsies: a prognosticator for personalised therapy in the era of precision oncology.
    Histopathology. 2026;88:970-984.
    PubMed         Abstract available

  73. YASUTAKE N, Yokawa Y, Tanaka T, Mishima R, et al
    Claudin-18 expression in gastric type adenocarcinoma and HPV-associated adenocarcinoma of the uterine cervix.
    Histopathology. 2026;88:1003-1015.
    PubMed         Abstract available


    Hum Pathol

  74. ZHANG Z, Quddus MR, Sung CJ, Singh K, et al
    Morphologic and immunohistochemical study of HPV-related cervical adenosquamous carcinoma: Reappraisal of a poorly defined entity.
    Hum Pathol. 2026;170:106052.
    PubMed         Abstract available


    Insights Imaging

  75. JIANG L, Ma S, Du Q, Lv J, et al
    Prognostic value of Node-RADS scoring in stage IIICr cervical cancer: development and validation of novel nomograms.
    Insights Imaging. 2026;17:64.
    PubMed         Abstract available


    Int Immunopharmacol

  76. ZHANG H, Liu C, Zhai X, Zhang Q, et al
    Disfunction of communication among immune cells in minimal-deviation adenocarcinoma of the cervix as an immunotherapeutic opportunity.
    Int Immunopharmacol. 2023;124.
    PubMed         Abstract available


    Int J Cancer

  77. KARRBERG C, Gray P, Elfgren K, Milerad H, et al
    Nationwide audit of cervical cancer screening reveals unsatisfactory triage strategies and trends over time in incidence among cytology negative women.
    Int J Cancer. 2026 Mar 9. doi: 10.1002/ijc.70415.
    PubMed         Abstract available

  78. LEHTINEN M, Lipsitch M, Pimenoff VN, Sundstrom K, et al
    Predicting optimal impact interventions in the post-HPV vaccination world.
    Int J Cancer. 2026 Jan 19. doi: 10.1002/ijc.70297.
    PubMed         Abstract available

  79. TSEGAYE AT, Mashele SA, Shing JZ, Mwansa-Kambafwile J, et al
    Race-specific temporal trends of HPV-related cancers in South Africa: An analysis of the South African National Cancer Registry, 2011-2022.
    Int J Cancer. 2025 Dec 31. doi: 10.1002/ijc.70323.
    PubMed         Abstract available

  80. LEI J, Falcaro M, Brentnall AR, O'Mahony JF, et al
    Indicators to identify cancer screening providers with suboptimal case detection: A scoping review.
    Int J Cancer. 2026;158:2339-2358.
    PubMed         Abstract available


    Int J Clin Oncol

  81. IWAHASHI N, Noguchi T, Sakai K, Yahata T, et al
    Comprehensive circulating tumor DNA mutation profiling via CAPP-Seq liquid biopsy for cervical cancer.
    Int J Clin Oncol. 2026 Mar 10. doi: 10.1007/s10147-026-03006.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  82. ZULFIKAROGLU E
    Cervical cancer screening strategies in women 65 years and older in the human papillomavirus era: A systematic review and meta-analysis of human papillomavirus-based testing and self-sampling approaches.
    Int J Gynaecol Obstet. 2026 Mar 12. doi: 10.1002/ijgo.70962.
    PubMed         Abstract available


    Int J Gynecol Cancer

  83. ZHOU J, Cai J, Li X, Liu C, et al
    Correspondence on "Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study".
    Int J Gynecol Cancer. 2026 Feb 11:104551. doi: 10.1016/j.ijgc.2026.104551.
    PubMed        

  84. SANTIA MC, Morante-Caicedo C, Pineros Castillo WA, Taylor A, et al
    Surgical de-escalation of cervical cancer treatment in limited-resource settings.
    Int J Gynecol Cancer. 2026 Mar 2:102862. doi: 10.1016/j.ijgc.2025.102862.
    PubMed         Abstract available

  85. VIVEROS-CARRENO D, Agusti N, Mora-Soto N, Wilke RN, et al
    De-escalation in definitive surgical management for cervical cancer.
    Int J Gynecol Cancer. 2025 Oct 9:102711. doi: 10.1016/j.ijgc.2025.102711.
    PubMed         Abstract available

  86. CAICEDO-MARTINEZ M, Arbelaez-Marino AF, Arbelaez L, Farach A, et al
    Refinement in radiotherapy treatment for locally advanced cervical cancer: a historic perspective.
    Int J Gynecol Cancer. 2026 Mar 2:102878. doi: 10.1016/j.ijgc.2025.102878.
    PubMed         Abstract available

  87. MORA-SOTO N, Viveros-Carreno D, Morante-Caicedo C, Pineros W, et al
    Neoadjuvant chemotherapy in cervical cancer: a narrative review.
    Int J Gynecol Cancer. 2026 Mar 2:102827. doi: 10.1016/j.ijgc.2025.102827.
    PubMed         Abstract available


    Int J Med Sci

  88. GUO Y, Li S, Liu T, Chang X, et al
    Gene Mutations and Related Molecular Events in Distant Metastasis of Cervical Cancer: A Review.
    Int J Med Sci. 2026;23:1015-1032.
    PubMed         Abstract available


    Int J Oncol

  89. KIM A, Kim J, Kwak W, Mo K, et al
    Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer.
    Int J Oncol. 2026;68:57.
    PubMed         Abstract available


    Int J Surg Pathol

  90. KAYALI E, Comert GK, Yildirim HT, Toptas T, et al
    Nicotinamide Phosphoribosyltransferase (NAMPT) as a New Marker in Cervical Preinvasive Lesions.
    Int J Surg Pathol. 2026;34:385-391.
    PubMed         Abstract available


    Int J Womens Health

  91. PAN G, Wang W, Sun Z, Chu R, et al
    High-Risk Clinical Characteristics and Risk Model for Unexpected Cervical Cancer Diagnosed After Surgery in Patients with LSIL/HSIL Biopsy.
    Int J Womens Health. 2026;18:584455.
    PubMed         Abstract available


    Iran J Immunol

  92. ZHANG J, Zhang Y, Zhang J
    BATF Drives Cervical Cancer Progression and Immune Evasion by Regulating the STAT1-PD-L1 Axis.
    Iran J Immunol. 2026;23.
    PubMed         Abstract available


    iScience

  93. CHENG Y, Wang J, Wang L, Yan D, et al
    Systemic immune-inflammatory index for the prediction of the survival in patients with cervical cancer: A meta-analysis.
    iScience. 2026;29:114862.
    PubMed         Abstract available


    J Biochem Mol Toxicol

  94. WANG J, Zhang Y, Wang H, Zhang J, et al
    Cystathionine-gamma-Lyase/Hydrogen Sulfide Axis Plays a Crucial Role in Promoting the Progression of Cervical Cancer.
    J Biochem Mol Toxicol. 2026;40:e70765.
    PubMed         Abstract available


    J Cachexia Sarcopenia Muscle

  95. SUROV A, Hohn AK, Hinnerichs M, Meyer HJ, et al
    Associations Between Body Composition and Intratumoural Immune Cells in Patients With Uterine Cervical Cancer.
    J Cachexia Sarcopenia Muscle. 2026;17:e70241.
    PubMed         Abstract available


    J Cancer Policy

  96. JUNIOR DST
    Incorporation of HPV-DNA molecular test into the Brazilian healthcare system.
    J Cancer Policy. 2026;47:100713.
    PubMed         Abstract available

  97. AZIM MR, Sakib QN, Rahman MM, Islam MS, et al
    Economic burden of breast, cervical, and oral cancer in Bangladesh: a cost-of-illness study.
    J Cancer Policy. 2026;47:100694.
    PubMed         Abstract available

  98. GAO T, Farag M, Agha S, Mobula L, et al
    Economic evaluation of the one-dose HPV vaccination program in Nigeria.
    J Cancer Policy. 2026;47:100675.
    PubMed         Abstract available

  99. DORJI N, Dorji T, Dorjey Y, Yangdon Y, et al
    Quality improvement initiatives on colposcopy and treatment of cervical pre-cancer services in Bhutan: Experiences, challenges, and way forward.
    J Cancer Policy. 2026;47:100676.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  100. WANG X, Shi W, Pu X, Hu Y, et al
    Development and validation of nomograms to recurrence and survival in patients with early-stage cervical adenocarcinoma.
    J Cancer Res Clin Oncol. 2023;149:13727-13739.
    PubMed         Abstract available

  101. THANGARAJAH F, Busshoff J, Salamon J, Pruss MS, et al
    Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer.
    J Cancer Res Clin Oncol. 2023;149:12597-12604.
    PubMed         Abstract available


    J Clin Microbiol

  102. ZHANG J, Wang H, Liu Y, Li Z, et al
    HPV testing with 16/18 genotyping for risk stratification among women with normal cytology: a multicenter prospective cohort study from China.
    J Clin Microbiol. 2026 Feb 19:e0128925. doi: 10.1128/jcm.01289.
    PubMed         Abstract available


    J Clin Oncol

  103. MASSAD LS
    Incremental Progress in the Cervical Cancer Screening Revolution.
    J Clin Oncol. 2026 Mar 2:JCO2503021. doi: 10.1200/JCO-25-03021.
    PubMed        


    J Community Health

  104. NGHIEM VTH, Smith S, Shi J, McBrayer A, et al
    Acceptability and Feasibility of Home-Based Human Papillomavirus Self-Testing as Primary Screening for Cervical Cancer Detection in the State of Alabama.
    J Community Health. 2026 Mar 6. doi: 10.1007/s10900-026-01554.
    PubMed         Abstract available


    J Gynecol Oncol

  105. KONGWATTANAKUL S, Petroch P, Nimjaroen K, Bawornpatarapakorn S, et al
    The effectiveness of a 3-dimensional printed vaginal dilator in mitigating radiation-induced vaginal stenosis for patients with cervical cancer.
    J Gynecol Oncol. 2026 Feb 24. doi: 10.3802/jgo.2026.
    PubMed         Abstract available

  106. LIN J, Wu Q, Liu B, He H, et al
    Neoadjuvant therapy of iparomlimab and tuvonralimab combined with chemotherapy-extenuated for locally advanced cervical cancer (NICE-CC): an investigator-initiated, multicentre, open-label, phase II trial.
    J Gynecol Oncol. 2026 Feb 9. doi: 10.3802/jgo.2026.
    PubMed         Abstract available


    J Immunother

  107. HE J, Cheng C, Ding Y, Li N, et al
    Design of Therapeutic Vaccines Based on Antigen Epitopes of alpha-9 HPV E6 in Sichuan.
    J Immunother. 2026;49:87-97.
    PubMed         Abstract available


    J Infect

  108. YAN M, Yang Y, Zhao Y, Ma L, et al
    Prevalence and genotype distribution of high-risk human papillomavirus infection among Chinese women aged 35-64: A national screening population-based study.
    J Infect. 2026;92:106697.
    PubMed         Abstract available


    J Infect Chemother

  109. KIHARA K, Kajiyama Y, Kimura Y, Okazaki S, et al
    Adult-onset botulism in a Japanese woman with prolonged spore excretion.
    J Infect Chemother. 2023;29:1172-1176.
    PubMed         Abstract available


    J Med Biochem

  110. CUI Y, Li Y, Na J, Lu J, et al
    Investigating the causal association between plasma lipids and the risk of squamous cervical cancer: A two-sample mendelian randomization study.
    J Med Biochem. 2025;44:1843-1849.
    PubMed         Abstract available


    J Obstet Gynaecol Res

  111. MATOBA Y, Oomori Y, Nishibuchi I, Uegami S, et al
    Reirradiation for Recurrent Cervical Cancer Within the Previous Radiation Field Using a Bioabsorbable Spacer: A Case Report.
    J Obstet Gynaecol Res. 2026;52:e70225.
    PubMed         Abstract available

  112. PENG Y, Wang L, Jin F, Su Z, et al
    Application of Manual Lymph Drainage Combined With Complex Decongestive Therapy in Lower Limb Lymphedema After Cervical Cancer Surgery and Its Impact on Quality of Life.
    J Obstet Gynaecol Res. 2026;52:e70217.
    PubMed         Abstract available


    J Prev (2022)

  113. KOVACEVIC IN, Jovanovic A, Ristic J, Milic N, et al
    Effect of Organized Cervical Cancer Screening Programs on Incidence and Mortality: A Systematic Review and Meta-analysis.
    J Prev (2022). 2026 Mar 4. doi: 10.1007/s10935-026-00908.
    PubMed         Abstract available


    J Public Health (Oxf)

  114. NAVARRO-TORNE A, Aris E, Callegaro A, Benninghoff B, et al
    Maximizing impact: the power of early HPV vaccination for long-term protection-lessons from a systematic review and meta-regression analysis.
    J Public Health (Oxf). 2026;48:216-227.
    PubMed         Abstract available

  115. NGUYEN-THANH H, Marshall L, Wilson H, Stewart K, et al
    Awareness of HPV-related cancers and the HPV vaccination programme in Scotland: a cross-sectional study of gender, deprivation and knowledge gaps.
    J Public Health (Oxf). 2026;48:239-248.
    PubMed         Abstract available


    J Theor Biol

  116. LINDWALL G, Gerlee P
    Bayesian inference on the Allee effect in cancer cell line populations using time-lapse microscopy images.
    J Theor Biol. 2023;574:111624.
    PubMed         Abstract available


    J Transl Med

  117. WU H, Yu Y, Wang W, Xu Q, et al
    SMC4/SMAD3/NF-kappaB axis drives cervical cancer progression and radioresistance via DNA damage repair and immune modulation.
    J Transl Med. 2026 Mar 9. doi: 10.1186/s12967-026-07979.
    PubMed         Abstract available


    JAMA Netw Open

  118. LIU X, Vidrine DJ, Sutton SK, Wetter DW, et al
    Cost-Effectiveness of Smoking Cessation Among Survivors of Cervical Intraepithelial Neoplasia or Cervical Cancer.
    JAMA Netw Open. 2026;9:e261543.
    PubMed         Abstract available

  119. GOTTSCHLICH A, Smith LW, Hong Q, Dabee S, et al
    HPV, Cytology, and Cotest Cervical Cancer Screening and the Risk of Precancer.
    JAMA Netw Open. 2026;9:e261304.
    PubMed         Abstract available


    JNMA J Nepal Med Assoc

  120. ANSARI SN, Kunwar R, Vaidya SA
    Immunohistochemical Expression of P16 in Cervical Lesions: An Observational Study.
    JNMA J Nepal Med Assoc. 2025;63:823-827.
    PubMed         Abstract available


    Med Chem

  121. KIRUTHIGA N, Krishnan S, Arulsamy S, Natarajan A, et al
    Design and Synthesis of Piperidine Hydroxamate Scaffolds as Novel HDAC Inhibitors with Apoptotic Potential in Human Cervical Cancer Cells.
    Med Chem. 2026 Mar 2. doi: 10.2174/0115734064378681251128061500.
    PubMed         Abstract available


    Medicine (Baltimore)

  122. CHEN X, Zheng X, Yang Z, Sui F, et al
    Clinicopathologic characteristics and survival outcomes of patients with high-grade neuroendocrine cervical cancer.
    Medicine (Baltimore). 2026;105:e47961.
    PubMed         Abstract available

  123. LI Y, Zhang W, Tang L, Zhu Y, et al
    Core targets of bisphenol A in cervical cancer revealed by network toxicology and molecular docking.
    Medicine (Baltimore). 2026;105:e47993.
    PubMed         Abstract available


    Microbiol Resour Announc

  124. TUSAR MTT, Ara R, Farazi R, Roy CR, et al
    Complete genome sequence of human papillomavirus type 45 identified from a cervical cancer patient in Bangladesh.
    Microbiol Resour Announc. 2026 Mar 10:e0138225. doi: 10.1128/mra.01382.
    PubMed         Abstract available


    Mil Med

  125. STOUT CE, Poiani LTH, Mcglynn A, Enujioke CDRSC, et al
    Recommendation for Human Papillomavirus Vaccine after Abnormal Pap Smear in Unvaccinated Active Duty Women.
    Mil Med. 2026;191.
    PubMed         Abstract available


    Nanomedicine

  126. ALI AA, McCrudden CM, McCaffrey J, McBride JW, et al
    DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles.
    Nanomedicine. 2026 Feb 27:102923. doi: 10.1016/j.nano.2026.102923.
    PubMed         Abstract available


    Nanomedicine (Lond)

  127. MAYUMI WADA C, Ferrari G, Silveira da Silva L, Pitton M, et al
    Intrauterine devices incorporating nanocarriers for targeted cervical cancer therapy.
    Nanomedicine (Lond). 2026 Mar 11:1-13. doi: 10.1080/17435889.2026.2641148.
    PubMed         Abstract available


    Nat Commun

  128. HASSINE A, Tisler A, Martel M, Bardou M, et al
    Risk of cervical cancer and high-grade lesions in vulnerable women a systematic review and meta-analysis.
    Nat Commun. 2026 Mar 2. doi: 10.1038/s41467-026-70050.
    PubMed         Abstract available


    Nature

  129. NITTA N, Sugiyama Y, Sugimura T, Ito T, et al
    Clinical-grade autonomous cytopathology through whole-slide edge tomography.
    Nature. 2026;651:472-481.
    PubMed         Abstract available


    Neuro Endocrinol Lett

  130. MADZARAC V, Culej D, Muzinic D, Zovko G, et al
    Small-cell neuroendocrine carcinoma of the cervix associated with adenocarcinoma in situ: A case report with analysis of molecular abnormalities.
    Neuro Endocrinol Lett. 2023;44:332-335.
    PubMed         Abstract available


    NPJ Precis Oncol

  131. ZHANG H, Luo X, Jiang J, Zhang C, et al
    The clinical application value of dynamic monitoring of HPV ctDNA in concurrent chemoradiotherapy for locally advanced cervical cancer.
    NPJ Precis Oncol. 2026 Mar 3. doi: 10.1038/s41698-026-01348.
    PubMed         Abstract available


    Nucleic Acids Res

  132. YANG T, Tang M, Xu L, Jiang L, et al
    A tailored phosphorothioate coordinator enables CRISPR/Cas in-situ amplification.
    Nucleic Acids Res. 2026;54:gkag187.
    PubMed         Abstract available


    Nutr Rev

  133. HUA Y, Li Y, Qin H, Huo M, et al
    Association Between Folate Status and Risk of Cervical Cancer: A Systematic Review, Dose-Response Meta-analysis, and Mendelian Randomization Study.
    Nutr Rev. 2026 Mar 11:nuag016. doi: 10.1093.
    PubMed         Abstract available


    Obstet Gynecol Sci

  134. KIM JH, Shim SH, Min KJ, Lee JK, et al
    Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk HPV testing in cervical cancer screening.
    Obstet Gynecol Sci. 2026 Mar 4. doi: 10.5468/ogs.26066.
    PubMed         Abstract available


    Phys Med Biol

  135. LIN S, Ouyang Y, Gu H, Chen K, et al
    Toward fully automated pre-implantation planning for cervical cancer brachytherapy: a template-guided multi-criteria optimization framework for catheter placement and dose distribution.
    Phys Med Biol. 2026 Mar 11. doi: 10.1088/1361-6560.
    PubMed         Abstract available


    PLoS One

  136. MITCHELL LE, Phillips E, Jennett CJ, Bavor C, et al
    Experiences of HPV self-collection among Aboriginal and Torres Strait Islander women and people with a cervix.
    PLoS One. 2026;21:e0326551.
    PubMed         Abstract available

  137. HASBAY E, Sahin S, Kelten Talu EC, Sanci M, et al
    MRI differentiation of usual type endocervical adenocarcinoma and cervical squamous cell carcinoma.
    PLoS One. 2026;21:e0343764.
    PubMed         Abstract available


    Radiat Oncol

  138. ZHU Y, Liu K, Yang Z, Peng Z, et al
    Machine-learning with multiomics for radiotherapy-induced acute rectal toxicities and survival outcome in patients with cervical cancer.
    Radiat Oncol. 2026 Mar 5. doi: 10.1186/s13014-026-02814.
    PubMed        


    Radiother Oncol

  139. MACKENZIE P, Vajdic C, Delaney G, Comans T, et al
    Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers.
    Radiother Oncol. 2023;188:109862.
    PubMed         Abstract available


    Reprod Toxicol

  140. ZI XJ, Li YL, Chu ZY
    Mechanisms of bisphenols-induced cervical cancer: A multidimensional bioinformatics analysis.
    Reprod Toxicol. 2026;141:109209.
    PubMed         Abstract available


    Res Sq

  141. GONZALEZ GMN, Inam ME, Msadabwe S, Lee KL, et al
    Social Determinants of Health Impact Cervical Cancer Stage at Presentation among Women in Zambia.
    Res Sq [Preprint]. 2026 Feb 23:rs.3.rs-8522732. doi: 10.21203/rs.3.rs-8522732.
    PubMed         Abstract available


    Rev Med Virol

  142. ZHENG L, Zhao G, Zheng L, Zou Y, et al
    Insights Into Highly Associated Co-Factors on HPV-Related Cervical Cancer.
    Rev Med Virol. 2026;36:e70131.
    PubMed         Abstract available

  143. MURAHWA AT, Dzobo M, Mahenge A, Rantshabeng P, et al
    The Burden of HPV35 in African Cervical Pathologies: Prevalence, Contributing Factors, and Vaccine Prospects.
    Rev Med Virol. 2026;36:e70129.
    PubMed         Abstract available


    RNA Biol

  144. BENCHEIKH S, Lemriss H, Souiri A, Akachar J, et al
    Human papillomavirus-encoded microRNAs: key regulators in cervical cancer development.
    RNA Biol. 2026;23:1-14.
    PubMed         Abstract available


    Sci Rep

  145. TRYBUS W, Trybus E, Krol T
    Alizarin induces a multidirectional mechanism of anti-cancer action in cervical cancer and prostate cancer cells.
    Sci Rep. 2026 Mar 10. doi: 10.1038/s41598-026-43011.
    PubMed         Abstract available

  146. ALSULAYS BB, Anwer MK, Hatata MN, Raish M, et al
    Development of beta-CD metal organic frameworks loaded with olaparib: a novel approach for the treatment of cervical cancer.
    Sci Rep. 2026 Mar 10. doi: 10.1038/s41598-026-43779.
    PubMed        

  147. HU D, Zhao Y, Han M, Qian W, et al
    Analysis of factors associated with cervical cancer and precancerous lesions.
    Sci Rep. 2026 Mar 9. doi: 10.1038/s41598-025-32215.
    PubMed         Abstract available

  148. ISLAM O, Assaduzzaman M, Akter S, Fahad N, et al
    Enhanced cervical cancer diagnosis using a novel Bayesian fusion ensemble method with explainable AI.
    Sci Rep. 2026 Mar 5. doi: 10.1038/s41598-026-35334.
    PubMed        

  149. MA X, Xu Z, Chen Y, Jiang F, et al
    KIF20A promotes cervical cancer progression by interacting with CLIP1.
    Sci Rep. 2026 Mar 3. doi: 10.1038/s41598-026-42883.
    PubMed        

  150. BI Y, Ye Y, Wu X, Cao H, et al
    Mechanism of isoleucyl-tRNA synthetase 2 regulating proliferation and apoptosis of cervical cancer cells.
    Sci Rep. 2026 Mar 2. doi: 10.1038/s41598-026-41218.
    PubMed        


    Semin Oncol Nurs

  151. FREIJOMIL-VAZQUEZ C, Gastaldo D
    The Intersecting Effects of Biomedicine and Patriarchy on the Social Lives of Women Undergoing Cervical Cancer Prevention.
    Semin Oncol Nurs. 2026 Feb 27:152173. doi: 10.1016/j.soncn.2026.152173.
    PubMed         Abstract available


    Sensors (Basel)

  152. VEGA C, Leon R, Medina N, Fabelo H, et al
    Design and Characterization of a Hyperspectral Colposcope Based on Dual-LCTF VNIR Narrow-Band Illumination.
    Sensors (Basel). 2026;26:1255.
    PubMed         Abstract available


    Taiwan J Obstet Gynecol

  153. CLAIRE LIN CC, Tai CC, Hung P, Tung YC, et al
    Corrigendum to "Community mobile health clinics' availability is associated with cervical cancer screening in rural and urban areas: A national cohort study in Taiwan" [Taiwan J Obstet Gynecol 64 (2025) 1024-1029].
    Taiwan J Obstet Gynecol. 2026;65:399.
    PubMed        

  154. ZHENG J
    Comment on "Recent advances in cervical cancer treatment: Innovations from early-stage to advanced disease".
    Taiwan J Obstet Gynecol. 2026;65:393.
    PubMed        

  155. WENG CS, Chen RC, Chen HJ, Tsay JY, et al
    Genotype-specific prevalence of high-risk human papillomavirus among cytologically normal women in Taiwan.
    Taiwan J Obstet Gynecol. 2026;65:292-298.
    PubMed         Abstract available

  156. WANG CC, Liu SH, Wu MH, Chen JR, et al
    Increased risk of ischemic stroke in cervical cancer patients received radiotherapy: A nationwide population-based study.
    Taiwan J Obstet Gynecol. 2026;65:247-255.
    PubMed         Abstract available


    Technol Cancer Res Treat

  157. XIAO G, Quan K, Zeng M, Ye Y, et al
    Region-specific Multi-Omics Modeling for Predicting Acute Radiation-Induced Proctitis in Cervical Cancer Radiotherapy: A Retrospective Analysis.
    Technol Cancer Res Treat. 2026;25:15330338261424144.
    PubMed         Abstract available


    Ther Adv Med Oncol

  158. MIAO Z, Yang XL, Zhu JW, Zhou YC, et al
    The differences of pelvic lymph node metastasis between squamous cell carcinoma and adenocarcinoma in early-stage cervical cancer patients undergoing radical surgery and adjuvant radiotherapy: a large cohort study.
    Ther Adv Med Oncol. 2026;18:17588359261425694.
    PubMed         Abstract available


    Transl Cancer Res

  159. LIANG H, Li Q, Liao Y, Huang H, et al
    Rosa roxburghii Tratt fruit polysaccharides inhibit proliferation and induce apoptosis in human cervical cancer cell line.
    Transl Cancer Res. 2026;15:121.
    PubMed         Abstract available


    Trials


  160. Prophylactic para-aortic irradiation vs pelvic radiotherapy in pelvic node-positive carcinoma cervix in the setting of concurrent chemoradiation: a phase II open-label multi centric randomized controlled trial (PRO-PARA).
    Trials. 2026;27:195.
    PubMed         Abstract available


    Virol J

  161. SHADANG M, Arumugam A, Singh DK, Keshari P, et al
    The R2TP complex stabilises E7 to drive human papillomavirus-mediated pathogenesis in cellular models of cervical cancer.
    Virol J. 2026;23:66.
    PubMed         Abstract available


    Virologie (Montrouge)

  162. POY M, Jacquot K, Gross S, Lepiller Q, et al
    [Development and distribution of an inter-laboratory comparison test for HPV testing].
    Virologie (Montrouge). 2026;30:63-69.
    PubMed         Abstract available

  163. CHARPENTIER C, Brousseau J, Jary A, Ferre VM, et al
    [Cervical cancer screening: what role for methylation tests?].
    Virologie (Montrouge). 2026;30:19-32.
    PubMed         Abstract available

  164. DOGHMAN I, Malassigne V, Roucaute L, Azais H, et al
    [Advances in screening and follow-up of HPV-related cervical cancer].
    Virologie (Montrouge). 2026;30:7-18.
    PubMed         Abstract available


    Viruses

  165. SAITO M, Rajesh A, Innes C, van der Griend R, et al
    The High-Risk Human Papillomavirus Type Influences the Tissue Microenvironment in Cervical Intraepithelial Neoplasia Grade 2.
    Viruses. 2023;15:1953.
    PubMed         Abstract available

  166. CHAIWONGKOT A, Buranapraditkun S, Oranratanaphan S, Chuen-Im T, et al
    Efficiency of CIN2+ Detection by Thyrotropin-Releasing Hormone (TRH) Site-Specific Methylation.
    Viruses. 2023;15:1802.
    PubMed         Abstract available


    Womens Health (Lond)

  167. WILLIAMS DM, Reilly S, Lord T, Ayers K, et al
    "Give me the sense that I matter:" Queer women's recommendations for an ideal cervical cancer screening exam and pathways to screening equity.
    Womens Health (Lond). 2026;22:17455057261428108.
    PubMed         Abstract available

  168. FASZHOLZ AM, Lozano V, Garda J
    Structure, utilization, and screening adherence of a student-run women's health clinic for uninsured Spanish-speaking women: A descriptive analysis.
    Womens Health (Lond). 2026;22:17455057261424823.
    PubMed         Abstract available


    World J Surg Oncol

  169. ZOU Z, Huang L, Yin K, Li Y, et al
    Effect of immune-related lncRNA BZRAP1-AS1/miR-541-3p and its molecular mechanism in cervical cancer.
    World J Surg Oncol. 2026 Mar 9. doi: 10.1186/s12957-026-04270.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum